Xin-yuan Lei
Kaifeng, 475001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
The role of HMGA1 in genome stability: Implications in human cancer.
Journal: Cellular and molecular life sciences : CMLS
Published: July 18, 2025
STING inhibits the progression of esophageal squamous cell carcinoma by suppressing CPT1A-mediated fatty acid β-oxidation.
Journal: Acta pharmacologica Sinica
Published: January 13, 2025
PARylation of HMGA1 desensitizes esophageal squamous cell carcinoma to olaparib.
Journal: Clinical and translational medicine
Published: April 11, 2024
HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis.
HMGA1 sensitizes esophageal squamous cell carcinoma to mTOR inhibitors through the ETS1-FKBP12 axis.
Journal: International journal of biological sciences
Published: February 22, 2024
High mobility group A1 (HMGA1) promotes esophageal squamous cell carcinoma progression by inhibiting STING-mediated anti-tumor immunity.
Journal: Nature communications
Published: January 12, 2024
High mobility group A1 (HMGA1) promotes the tumorigenesis of colorectal cancer by increasing lipid synthesis.
Journal: Nature communications
Published: November 05, 2023
HMGA1 promotes the progression of esophageal squamous cell carcinoma by elevating TKT-mediated upregulation of pentose phosphate pathway.
Journal: Cell death & disease
Published: August 27, 2023
Development and management of gastrointestinal symptoms in long-term COVID-19.
Journal: Frontiers in microbiology
Published: August 16, 2023
HMGA1 drives chemoresistance in esophageal squamous cell carcinoma by suppressing ferroptosis.
Journal: Cell death & disease
Published: July 04, 2023
Showing 1-10 of 10
Last Updated: 09/26/2026